ConductScience.org, home

Paper45131

Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites.

Cohen BM and 2 others. Psychiatry Res, 1979. Cited by 71 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites. Papers, record 45131. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/45131

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites.
PubMed
Journal
Psychiatry Res
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
3.64
iCite
Revised in PubMed
2019-08-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cohen BMB M
2Herschel MM
3Aoba AA

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
ChlorpromazineMajor topic
ParasympatholyticsMajor topic
SympatholyticsMajor topic
ThioridazineMajor topic
Animals
Cattle
In Vitro Techniques
Radioligand Assay

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MH-30511NIMH NIH HHSUnited StatesPubMed
MH-31154NIMH NIH HHSUnited StatesPubMed

Source PubMed

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
41,257,995Nationwide health claims analysis of phenothiazine-associated retinopathy risk in chlorpromazine and perphenazine users.Sci Rep2025https://conductscience.org/library/papers/41257995PubMed
30,142,909Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity.Molecules2018https://conductscience.org/library/papers/30142909PubMed
25,864,631Structural basis of arc binding to synaptic proteins: implications for cognitive disease.Neuron2015https://conductscience.org/library/papers/25864631PubMed
12,709,776Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12709776PubMed
6,133,307Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6133307PubMed
6,133,301Sedative effects and prolactin response to single oral doses of melperone.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6133301PubMed
6,133,299Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6133299PubMed
6,126,895Serum neuroleptic concentrations and tardive dyskinesia.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6126895PubMed
6,107,947Neuroleptic blood levels and therapeutic effect.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6107947PubMed
3,097,710Fluphenazine activity and antipsychotic response.Psychopharmacology (Berl)1986https://conductscience.org/library/papers/3097710PubMed
2,875,481Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate.Psychopharmacology (Berl)1986https://conductscience.org/library/papers/2875481PubMed
2,580,329Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/2580329PubMed
2,498,945A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2498945PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/45131

GET https://conductscience.org/api/papers/v1/45131/authors